Treatment of Antibiotic Resistance including MRSA and VRE
With the advent of readily available antibiotics the development of bacterial resistance has become an increasingly common problem. Antibiotic resistance develops when bacteria are exposed to continued antibiotic use and subsequent generations of bacteria develop immunity to the drugs.
Methicillin resistant Staphylococcus aureus (MRSA) has become an increasingly common community acquired pathogen, causing skin and soft tissue infections, bone and joint infections, and even pneumonia.
The clinicians at SEHID take a comprehensive approach to the eradication of MRSA in their patients. This includes the elimination of the carrier state as well as treating acute infection. Our clinicians also screen and treat household contacts that may also harbor the bacteria.
Vancomycin resistant enterococcus (VRE) is the second most common resistant gram positive bacteria found in today's clinical environment, but fortunately it is more likely to cause a carrier state than an invasive infection.
Appropriate antibiotic therapy is absolutely crucial in combating these resistant bacteria in order to eradicate infection. Infectious disease physicians have specialized training in dealing with and managing antibiotic resistance.